MYL News and Press, Mylan N.V. From 05/28/20

Antares Pharma (NASDAQ: ATRS) is one of the fastest-growing biotech stocks in the sector, with multiple collaboration agreements with large-cap pharmaceutical companies to supply it with pressure-assisted injector devices. The wheel of fortune, however, has not been kind to Antares, as its ...

This article is part of a series that provides an ongoing analysis of the changes made to John Paulson’s 13F stock portfolio on a quarterly basis. It is based on Paulson’s regulatory 13F Form filed on 05/15/2020. Please visit our Tracking John Paulson’s Paulson & Co...

A just-published study in the journal Lancet may dampen the enthusiasm for using chloroquine and hydroxychloroquine to treat COVID-19 patients. More news on: Mylan N.V., Sanofi, Teva Pharmaceutical Industries Limited, Healthcare stocks news, Read more ...

Pfizer ( PFE ) is a major international pharmaceutical company that is currently in the process of transitioning its core business. In the late 2000s, Pfizer made numerous acquisitions, which have resulted in the company experiencing multiple restructuring costs, cutting their dividend in 2008...

GlaxoSmithKline (NYSE: GSK) and Pfizer (NYSE: PFE) have both been in the headlines lately as they lead the way in the race to develop a coronavirus vaccine. While it hasn't been an easy year for many household names in the big-pharma space, these two companies entered the coronavirus bea...

With earnings season in the rear-view mirror for the specialty pharmaceutical sector, J.P. Morgan is updating its positioning on the sector as the COVID-19 pandemic marches on - reiterating its favorites in the area and issuing downgrades to a couple of companies facing challenges. More ne...

The big news regarding  Pfizer (NYSE: PFE) these days centers on its search for a COVID-19 vaccine, but that just obscures more important news for investors. This solid, 171-year-old, diversified pharmaceutical company with more than 88,000 employees looks to have a nice surprise in stor...

HERTFORDSHIRE, England and PITTSBURGH , May 13, 2020 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that Executive Chairman Robert J. Coury and President Rajiv Malik will present at the 2020 RBC Capital Markets' Virtual Global Healthcar...

Mylan (NASDAQ: MYL) announced on Tuesday that it has entered into a global partnership with Gilead Sciences (NASDAQ: GILD) to manufacture and distribute remdesivir in 127 low- and middle-income countries as a treatment for COVID-19 . Remdesivir showed promise against the novel coronavir...

HERTFORDSHIRE, England and PITTSBURGH , May 12, 2020 /PRNewswire/ --  Mylan N.V.  (NASDAQ: MYL) today announced, as part of its ongoing efforts to support patients and public health needs during the COVID-19 pandemic, a global collaboration with Gilead Sciences to expand acces...